Felix Zwicker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Felix Zwicker has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Klaus Herfarth
Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany
3 shared publications - Jürgen Debus
Department of Radiation Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany
2 shared publications - Benedict Swartman
Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
1 shared publication - Christian Thieke
Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
1 shared publication - Florian Sterzing
Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
1 shared publication - Frank W. Hensley
Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
1 shared publication
Latest Publications
- Open Access
- 29 July 2012
- Published by Springer Nature in Radiation Oncology
- Vol. 7 (1) , 118
Total skin electron beam therapy as palliative treatment for cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemia
To retrospectively access the outcome and toxicity of a total skin electron beam therapy (TSEBT) in patients with cutaneous lymphoma (CL) or leukemia.
- 29 July 2012
- Published by Springer Nature in Radiation Oncology
- Vol. 7 (1) , 118
Open AccessTotal skin electron beam therapy as palliative treatment for cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemia
To retrospectively access the outcome and toxicity of a total skin electron beam therapy (TSEBT) in patients with cutaneous lymphoma (CL) or leukemia.
- Open Access
- 7 June 2011
- Published by Springer Nature in Radiation Oncology
- Vol. 6 (1) , 62
Biological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-H2AX immunofluorescence staining: 3D conformal- vs. step-and-shoot IMRT of the prostate gland
Different radiation-techniques in treating local staged prostate cancer differ in their dose- distribution. Physical phantom measurements indicate that for 3D, less healthy tissue is exposed to a relatively higher dose compared to SSIMRT. The purpose is to substantiate a dose distribution in lymphocytes in-vivo and to discuss the possibility of comparing it to the physical model of total body dose distribution.
- 7 June 2011
- Published by Springer Nature in Radiation Oncology
- Vol. 6 (1) , 62
Open AccessBiological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-H2AX immunofluorescence staining: 3D conformal- vs. step-and-shoot IMRT of the prostate gland
Different radiation-techniques in treating local staged prostate cancer differ in their dose- distribution. Physical phantom measurements indicate that for 3D, less healthy tissue is exposed to a relatively higher dose compared to SSIMRT. The purpose is to substantiate a dose distribution in lymphocytes in-vivo and to discuss the possibility of comparing it to the physical model of total body dose distribution.
- 1 January 2008
- Published by S. Karger AG in Onkologie
- Vol. 31 (10) , 6
Palliative Radiotherapy of Retrobulbar Orbit Metastases due to Breast Cancer
In breast cancer, the occurrence of retrobulbar metastases of the orbit is rare compared to intraocular metastases. The clinical symptoms are quite different. Impairment of vision, exophthalmus, double vision, vertigo, and pain reduce patients' quality of life. The benefit of palliative irradiation of the orbit was researched retrospectively in 7 patients. This report also presents the first case in the literature of a breast cancer patient with bi-orbital enophthalmus caused by bilateral retrobulbar metastases that were successfully treated with radiotherapy. Irradiation was performed by photon or electron beams (20-50 Gy). Clinical restaging was done at the end of radiotherapy and 6 weeks thereafter. After irradiation, 6 out of 7 patients showed a distinct clinical response with good palliation and no major side effects. Exophthalmus, pain, and vertigo were significantly reduced in all cases. Double vision disappeared in 3 out of 4 patients, eye muscle paralysis in 5 out of 6 patients. The median overall survival after irradiation of the orbit was 7.3 months. Palliative radiotherapy of retrobulbar metastases of breast cancer is very effective in reducing acute clinical symptoms and increasing quality of life. Nonetheless, patients have a poor prognosis.
- 1 January 2008
- Published by S. Karger AG in Onkologie
- Vol. 31 (10) , 6
Palliative Radiotherapy of Retrobulbar Orbit Metastases due to Breast Cancer
In breast cancer, the occurrence of retrobulbar metastases of the orbit is rare compared to intraocular metastases. The clinical symptoms are quite different. Impairment of vision, exophthalmus, double vision, vertigo, and pain reduce patients' quality of life. The benefit of palliative irradiation of the orbit was researched retrospectively in 7 patients. This report also presents the first case in the literature of a breast cancer patient with bi-orbital enophthalmus caused by bilateral retrobulbar metastases that were successfully treated with radiotherapy. Irradiation was performed by photon or electron beams (20-50 Gy). Clinical restaging was done at the end of radiotherapy and 6 weeks thereafter. After irradiation, 6 out of 7 patients showed a distinct clinical response with good palliation and no major side effects. Exophthalmus, pain, and vertigo were significantly reduced in all cases. Double vision disappeared in 3 out of 4 patients, eye muscle paralysis in 5 out of 6 patients. The median overall survival after irradiation of the orbit was 7.3 months. Palliative radiotherapy of retrobulbar metastases of breast cancer is very effective in reducing acute clinical symptoms and increasing quality of life. Nonetheless, patients have a poor prognosis.
- 1 June 2007
- Published by Springer Nature in Der Ophthalmologe
- Vol. 105 (2) , 170-172
Palliative Strahlentherapie einer retrobulbären Metastase beim Harnblasenkarzinom
Retrobulbäre Orbitametastasen beim Urothelkarziom der Harnblase sind sehr selten. In diesem Beitrag wird eine erfolgreiche palliative Bestrahlung einer retrobulbären Metastase eines Urothelkarzinoms mit akuten klinischen Symptomen wie Protrusio bulbi, Augenmotilitätsstörungen und Doppelbildern bei einem 50-jährigen Patienten beschrieben. Durch die Strahlenterapie konnte eine rasche Verbesserung der Protrusio und der Augenmuskelfunktionsstörung ohne Nebenwirkungen erreicht werden. Die Lebensqualität des Patienten wurde deutlich gebessert.
- 1 June 2007
- Published by Springer Nature in Der Ophthalmologe
- Vol. 105 (2) , 170-172
Palliative Strahlentherapie einer retrobulbären Metastase beim Harnblasenkarzinom
Retrobulbäre Orbitametastasen beim Urothelkarziom der Harnblase sind sehr selten. In diesem Beitrag wird eine erfolgreiche palliative Bestrahlung einer retrobulbären Metastase eines Urothelkarzinoms mit akuten klinischen Symptomen wie Protrusio bulbi, Augenmotilitätsstörungen und Doppelbildern bei einem 50-jährigen Patienten beschrieben. Durch die Strahlenterapie konnte eine rasche Verbesserung der Protrusio und der Augenmuskelfunktionsstörung ohne Nebenwirkungen erreicht werden. Die Lebensqualität des Patienten wurde deutlich gebessert.